YOu'd have to say, that unlike her predecessor, Rowena is likely to fulfill some of her flagged guidance of potential agreements.
Perhaps as little as a 1 in 3 chance if they "in early January 2024, successfully progressed to a shortlist of preferred suppliers in one competitive process with respect to potential offtake for the Dubbo Project" and one of the many US/AU discussions and sample avenues must surely lead to something?
But like her predecessor, Rowena is starting to slip behind on results vs her guidance of expectations, if not to the same proportions, if one looks at late 2022/early 2023 comments. Its a delicate balance of keeping investors well informed on pathways and over promising on likely success therein.
- Forums
- ASX - By Stock
- ASM
- Ann: Quarterly Activities/Appendix 5B Cash Flow Report
ASM
australian strategic materials limited
Add to My Watchlist
2.88%
!
50.5¢

Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-13
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
50.5¢ |
Change
-0.015(2.88%) |
Mkt cap ! $91.57M |
Open | High | Low | Value | Volume |
52.5¢ | 54.0¢ | 50.5¢ | $210.6K | 401.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 28242 | 50.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
52.0¢ | 778 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 28242 | 0.505 |
15 | 163900 | 0.500 |
3 | 9020 | 0.495 |
2 | 12600 | 0.490 |
3 | 52100 | 0.480 |
Price($) | Vol. | No. |
---|---|---|
0.520 | 778 | 1 |
0.525 | 10066 | 2 |
0.535 | 58947 | 2 |
0.540 | 26826 | 4 |
0.545 | 2756 | 2 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
ASM (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online